Clinical and microbiological characteristics of urine culture-confirmed genitourinary tuberculosis at medical centers in Taiwan from 1995 to 2007

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 3, 2011, Pages 319-326

  Hsu, H L ^a   Lai, C C ^c   Yu, M C ^a   Yu, F L ^a   Lee, J C ^a   Chou, C H ^b   Tan, C K ^c   Yang, P C ^b   Hsueh, P R ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; RIFABUTIN; RIFAMPICIN; STEROID; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLUSTER ANALYSIS; COMORBIDITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TAIWAN; TREATMENT OUTCOME; URINE CULTURE; UROGENITAL TUBERCULOSIS;

AGED; ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS, UROGENITAL; URINE;

EID: 79951724050     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1083-z     Document Type: Article

References (36)

1. World Health Organization: Global tuberculosis control: epidermiology, surveillance, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411.Geneva 2009. Available at: http://www.who.int/tb/publications/global-report/2009/en/ index.html
2. Mehta JB, Dutt A, Harvill L, Mathews KM (1991) Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 99:1134-1138
3. Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM (2002) Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis 6:879-886 (Pubitemid 35190701)
4. Pehme L, Hollo V, Rahu M, Altraja A (2005) Tuberculosis during fundamental societal changes in Estonia with special reference to extrapulmonary manifestations. Chest 127:1289-1295 (Pubitemid 46224293)
5. Center for Disease Control for Taiwan: Statistics of communicable diseases and surveillance report, Republic of China, 2007. Available at: http://www.cdc.gov.tw/np.asp?ctNode=1766&mp=5
6. Chen TM, Lee PY, Perng RP (1991) Extrapulmonary tuberculosis: experience at Veterans General Hospital-Taipei, 1985 to 1987. J Formos Med Assoc 90:1163-1170
7. Gow JG (2002) Genitourinary tuberculosis. In: Walsh PC et al (eds) Campbell's urology, 8th edn. Saunders, Philadelphia
8. Hsieh HC, Lu PL, Chen YH, Chen TC, Tsai JJ, Chang K et al (2006) Genitourinary tuberculosis in a medical center in southern Taiwan: an eleven-year experience. J Microbiol Immunol Infect 39:408-413 (Pubitemid 46050712)
9. World Health Organization: Treatment of tuberculosis: guidelines for national programmes, 3rd edn. WHO/CDS/TB/2003.313. Geneva 2003. Available at: http://www.who.int/tb/publications/cds-tb-2003-313/en/index.html
10. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN et al (2003) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167:603-662
11. World Health Organization: Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency Update 2008. WHO/HTM/TB/2008.402.Geneva 2008. Available at http://www.who.int/tb/publications/2008/programmatic- guidelines-for-mdrtb/en/index.html
12. Pfyffer GE (2007) Mycobacterium: general characteristics, laboratory detection, and staining procedures. In: Patrick R, Murray EJB, James H, Jorgensen MLL, Pfaller MA (eds) Manual of clinical microbiology, vol. 1, 9th edn. American Society for Microbiology, Washington, DC
13. Clinical and Laboratory Standards Institute (2008) Susceptibility testing of Mycobacteria, Nocardiae, and other aeroblic Actinomycetes: approved standards. CLSI, Wayne, PA, USA
14. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA et al (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6:23
15. Friedman CR, Stoeckle MY, Johnson WD Jr, Riley LW (1995) Double-repetitive-element PCR method for subtyping Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 33:1383-1384
16. Orakwe JC, Okafor PI (2005) Genitourinary tuberculosis in Nigeria; a review of thirty-one cases. Niger J Clin Pract 8:69-73
17. Altintepe L, Tonbul HZ, Ozbey I, Guney I, Odabas AR, Cetinkaya R et al (2005) Urinary tuberculosis: ten years' experience. Ren Fail 27:657-661 (Pubitemid 41748115)
18. Gokce G, Kilicarslan H, Ayan S, Tas F, Akar R, Kaya K et al (2002) Genitourinary tuberculosis: a review of 174 cases. Scand J Infect Dis 34:338-340 (Pubitemid 34746251)
19. Centers for Disease Control, Department of Health, Executive Yuan, 2008. Republic of China: Taiwan Tuberculosis Control Report 2008. Centers for Disease Control, Department of Health, Executive Yuan, Republic of China. Available at: http://www.cdc.gov.tw/lp.asp?ctNode=1947&CtUnit=1105&BaseDSD=31&mp=1
20. Centers for Disease Control, Department of Health, Executive Yuan, 2007. Republic of China: Taiwan Tuberculosis Control Report 2007. Centers for Disease Control, Department of Health, Executive Yuan, Republic of China. Available at: http://www.cdc.gov.tw/lp.asp?ctNode=1947&CtUnit=1105&BaseDSD=31&mp=1
21. Nzerue C, Drayton J, Oster R, Hewan-Lowe K (2000) Genitourinary tuberculosis in patients with HIV infection: clinical features in an inner-city hospital population. Am J Med Sci 320:299-303
22. Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC et al (2008) Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis 47:e57-e63
23. Liaw YS, Hsueh PR, Yu CJ, Wang SK, Yang PC, Luh KT (2004) Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002. J Formos Med Assoc 103:671-677
24. Dou HY, Tseng FC, Lin CW, Chang JR, Sun JR, Tsai WS et al (2008) Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect Dis 8:170
25. Feng JY, Su WJ, Tsai CC, Chang SC (2008) Clinical impact of mycobacterium tuberculosis W-Beijing genotype strain infection on aged patients in Taiwan. J Clin Microbiol 46:3127-3129
26. Jou R, Chiang CY, Huang WL (2005) Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol 43:95-100 (Pubitemid 40096285)
27. Park YK, Shin S, Ryu S, Cho SN, Koh WJ, Kwon OJ et al (2005) Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 63:165-172 (Pubitemid 41444246)
28. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA (2002) Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 40:1930-1937 (Pubitemid 34596365)
29. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K et al (2000) Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 6:302-305 (Pubitemid 30396388)
30. Augustynowicz-Kopec E, Zwolska JT (2008) Genetic diversity of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Poland and assessed by spoligotyping. J Clin Microbiol 46:4041-4044
31. Werngren J, Hoffner SE (2003) Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J Clin Microbiol 41:1520-1524 (Pubitemid 36428098)
32. Gori A, Bandera A, Marchetti G, Degli Esposti A, Catozzi L, Nardi GP et al (2005) Spoligotyping and Mycobacterium tuberculosis. Emerg Infect Dis 11:1242-1248 (Pubitemid 41045333)
33. Bauer J, Andersen AB, Kremer K, Miörner H (1999) Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol 37:2602-2606 (Pubitemid 29337286)
34. Sola C, Horgen L, Maïsetti J, Devallois A, Goh KS, Rastogi N (1998) Spoligotyping followed by double-repetitive-element PCR as rapid alternative to IS6110 fingerprinting for epidemiological studies of tuberculosis. J Clin Microbiol 36:1122-1124 (Pubitemid 28146311)
35. Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, Hwang JJ et al (2008) The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 36:335-340
36. Chiang CY, Lee JJ, Yu MC, Enarson DA, Lin TP, Luh KT (2009) Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis 13:105-111